Teleflex Nabs Expanded Indication for UroLift System

January 8, 2020

The FDA has handed Teleflex clearance for expanded indication of its UroLift system, a one-time, in-office treatment that improves urinary function in patients with enlarged prostates.

The system, which uses permanent implants placed with an inserted delivery device, is now cleared for treating men with prostates sized between 80 and 100cc.

The minimally-invasive technology is placed using a procedure that requires no cutting or removal of prostate tissue.

View today's stories